glp 1 compound lawsuit Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots Telehealth Companies Sued for Selling

doi: 10.3389/fcell.2025.1598794 Received 24 March 2025 Accepted 25 July 2025 Published 11 August 2025 Volume 13 - 2025 Edited by Katarzyna Nazimek, Jagiellonian University Medical College, Poland Reviewed by Giuseppe Petito, University of Campania Luigi Vanvitelli, Italy Maciej Suski, Jagiellonian University Medical College, Poland Updates Copyright 2025 Yin and Guo

Addressing both musculoskeletal repair and gut health at once makes the stack valuable for whole-body research

Trials were included if they compared any GLP-1RA medication to placebo or another active treatment and reported validated measures of binge eating or related eating behaviors, such as loss-of-control eating and disinhibited eating

J Dermatol Sci 61:16